Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$83.83+1.73 (+2.11%)
Close on Nov 18, 2026Market cap $6.58BP/E –Yield –
Abivax gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Abivax
Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?